The potential appointment of RFK Jr. as Secretary of Health and Human Services has raised concerns about the implications for the medical devices sector.
His focus on stricter regulatory oversight could improve device reliability but may also slow down market access and hinder innovation.
Kennedy"s policies could also impact the domestic supply chain, promoting resilience and sustainability but potentially increasing costs for smaller manufacturers.
Additionally, his advocacy for healthcare decentralization could drive investments in portable diagnostics and telehealth, but digital infrastructure and accessibility disparities need to be addressed.
Transparency is another priority, with proposed regulations requiring detailed data from manufacturers, which could enhance trust but increase compliance costs.
Finally, Kennedy"s environmental advocacy may promote sustainable practices in the medical device manufacturing sector, but smaller companies may need support to implement these changes.